Work

Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase

Year: 2001

Type: article

Source: Inflammation Research

DOI: 10.1007/pl00000234

Authors: J. G. Mabley, P. Jagtap, M. Perretti, S. J. Getting, A. L. Salzman, L. Virág, É. Szabó, F. G. Soriano, L. Liaudet, G. E. Abdelkarim, G. Haskó, A. Marton, G. J. Southan, C. Szabó

Institutions: Queen Mary University of London, William Harvey Research Institute, Rutgers, The State University of New Jersey, Rutgers New Jersey Medical School

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Eye Institute, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: NOVEL PARS INHIBITOR FOR THE THERAPY OF COLITIS, PARS and peroxynitrite induced cell death, ANTI-INFLAMMATORY AGENT EXPERIMENTAL THERAPY OF UVEITIS, ORALLY ACTIVE INHIBITOR OF POLY (ADP) RIBOSE SYNTETHASE

OpenAlex ID: W2146830757

FWCI: 4.888

Cites: 35

Cited by: 137

Related to: 10